AltheaDx Explores Desktop NGS Platforms for Cancer Gene Panels

"We are being fairly brave in terms of adopting those clinically focused platforms," according to the company's CSO. "The moment we believe they are robust enough, we are pulling them into the lab and trying them out."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.